Clinical Trial Update: A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing SU011248 plus paclitaxel versus bevacizumab plus paclitaxel in patients with advanced breast cancer has completed, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• PACLITAXEL (PACLITAXEL)
• SU011248

Snippet

Sponsor: Pfizer | Conditions: Breast Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2010-10-08